A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m2 for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 5563-5563 ◽  
Author(s):  
M. G. Fury ◽  
E. J. Sherman ◽  
D. M. Lisa ◽  
N. Agarwal ◽  
K. M. Algazy ◽  
...  
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Randomized Phase Ii ◽  
Neck Squamous Cell Cancer

scholarly journals Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

2017 ◽  
Vol 22 (7) ◽  
pp. 782 ◽  
Author(s):  
Marco Siano ◽  
Francesca Molinari ◽  
Vittoria Martin ◽  
Nicolas Mach ◽  
Martin Früh ◽  
...  
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Advanced Head ◽  
Multicenter Phase ◽  
Neck Squamous Cell Cancer

A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer

Cancer ◽  
1990 ◽  
Vol 66 (4) ◽  
pp. 640-644 ◽  
Author(s):  
Eduardo Tellez-Bernal ◽  
Gonzalo Recondo ◽  
Thierry Guillot ◽  
Mohamed Benhamed ◽  
Christian Domenge ◽  
...  
Keyword(s):  
Head And Neck ◽  
Continuous Infusion ◽  
Phase Ii ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Neck Squamous Cell Cancer

Phase II study of bevacizumab with docetaxel and radiation in locally advanced head and neck squamous cell cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 6071-6071 ◽  
Author(s):  
P. Savvides ◽  
J. Greskovich ◽  
J. A. Bokar ◽  
A. Narayan ◽  
W. van Heeckeren ◽  
...  
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Locally Advanced ◽  
Advanced Head ◽  
Neck Squamous Cell Cancer
Sign in / Sign up

Export Citation Format

Share Document